MedPath

Treatment of Temporomandibular Joint Disorders With a Stabilizing Occlusal Splint in Somatosensory Tinnitus

Not Applicable
Recruiting
Conditions
Tinnitus
TMJ
Temporomandibular Disorders (TMD)
Registration Number
NCT07211711
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

This clinical trial aims to investigate whether treatment of temporomandibular joint disorder with a stabilizing occlusal splint is justified to alleviate somatosensory tinnitus. The main questions we aim to answer are:

* Determine if treatment of temporomandibular disorder with a stabilizing occlusal splint improves somatosensory tinnitus.

* Identify which patient-related, tinnitus-related, and temporomandibular disorder-related factors contribute to the therapeutic effect.

Detailed Description

The clinical variables of somatosensory tinnitus (ZS) will be assessed by a researcher blinded to the treatment type, using the Tinnitus Handicap Inventory (THI) and Visual Analogue Scale (VAS) at time points T1, T2, T3, T4, and T5, with 30 days interval. The THI, validated and adapted to Portuguese, is the most frequently used questionnaire in clinical trials for tinnitus patients, quantifying the subjective impact of tinnitus on quality of life across three main domains: functional, emotional, and catastrophic. THI classifies tinnitus into five grades: (a) I - negligible (0-16); (b) II - mild (18-36); (c) III - moderate (38-56); (d) IV - severe (58-76); (e) V - catastrophic (78-100). Audiometry and psychoacoustic measures of tinnitus (pitch, loudness, minimum masking level) will be performed at T1 and T5 by an audiologist blind to the treatment group.

The clinical variables of temporomandibular dysfunction (TMD) will also be assessed by a researcher blinded to the treatment type, using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and VAS at the same time points. The DC/TMD is a validated tool, adapted to Portuguese, used in clinical trials that provides a systematic assessment, including a standardized clinical examination and questionnaires. This classification system, based on the biopsychosocial model of pain, includes a physical assessment through Axis I, using reliable and well-operationalized diagnostic criteria, and an assessment of the psychosocial status and pain-related disability through Axis II.

Both assessments will be conducted at T1, T2, T3, T4, and T5.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Patients over 18 years old;
  • Sufferers of somatosensory tinnitus and TMD for more than 6 months;
  • Dentition in good health, with at least minimal occlusion up to the second premolars on both sides;
  • Availability for at least 4 months of follow-up;
  • Able to speak and read the Portuguese language.
Exclusion Criteria

Pregnant patients; Treatment for TMD in the last 3 months; Treatment for tinnitus in the last 3 months; Use of total or partial removable prostheses Presence of orofacial pain disorders not related to TMD; Medical contraindication to treatment; Reluctance to accept any designated treatment; Unable or unwilling to give informed consent; Language barrier or delay in neuropsychomotor development.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in somatosensory tinnitus after treatment of temporomandibular joint disorder with a stabilizing occlusal splint.From enrollment to the end of treatment at 4 months

Tinnitus improvement was monitored using the tinnitus handicap inventory (THI). A 25-item questionnaire measuring tinnitus-related distress. Scores range from 0 to 100. It subjectively quantifies the impact of tinnitus on the patient's quality of life and classifies tinnitus into 5 degrees: I- negligible (0-16); II- mild (18-36); III- moderate (38-56); IV- severe (58-76); V- catastrophic (78-100).

Secondary Outcome Measures
NameTimeMethod
Somatosensory tinnitus distress reduction after treatment of temporomandibular joint dysfunction with a stabilizing occlusal splint.From enrollment to the end of treatment at 4 months

Tinnitus distress was monitored by a Visual Analog Scale (VAS): Patients rated tinnitus distress on 10-point scale (0 = none; 10 = extreme)

Trial Locations

Locations (1)

University of São Paulo Faculty of Medicine Clinics Hospital

🇧🇷

São Paulo, São Paulo, Brazil

University of São Paulo Faculty of Medicine Clinics Hospital
🇧🇷São Paulo, São Paulo, Brazil
Gustavo G Machado, Msc
Sub Investigator
Jeanne da Rosa Oiticica Ramalho RO Ramalho, PhD
Principal Investigator
Matheus Corrêa-Silva, DDs
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.